Clinical Drug Trials in Alzheimer's Disease
- 1 May 1985
- journal article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 444 (1 Memory D) , 428-436
- https://doi.org/10.1111/j.1749-6632.1985.tb37605.x
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Cholinesterase Inhibitors and Opiate Antagonists in Patients with Alzheimer's DiseaseNew England Journal of Medicine, 1983
- Oral physostigmine and lecithin improve memory in Alzheimer diseaseAnnals of Neurology, 1983
- Effects of Naloxone in Senile Dementia: A Double-Blind TrialNew England Journal of Medicine, 1983
- Loss of neurons of origin of the adrenergic projection to cerebral cortex (nucleus locus ceruleus) in senile dementiaNeurology, 1982
- The effects of oxiracetam (ISF 2522) in patients with organic brain syndrome (a double‐blind controlled study with piracetam)Drug Development Research, 1982
- Cerebral VasodilatorsNew England Journal of Medicine, 1981
- Profound effects of combining choline and piracetam on memory enhancement and cholinergic function in aged ratsNeurobiology of Aging, 1981
- Physostigmine and Arecoline: Effects of Intravenous Infusions in Alzheimer Presenile DementiaThe British Journal of Psychiatry, 1981
- Langzeittherapie altersbedingter Insuffizienzerscheinungen des GehirnsDeutsche Medizinische Wochenschrift (1946), 1978
- The effect of methylphenidate on test performance in the cognitively impaired agedPsychopharmacology, 1977